日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

NKG2A gene variant predicts outcome of immunotherapy in AML and modulates the repertoire and function of NK cells

NKG2A基因变异可预测急性髓系白血病(AML)免疫治疗的疗效,并调节NK细胞的谱系和功能。

Brwa Ali Hussein # ,Linnea Kristenson # ,Silvia Pesce ,Anne Wöhr ,Yarong Tian ,Alexander Hallner ,Mats Brune ,Kristoffer Hellstrand ,Ka-Wei Tang ,Elin Bernson ,Fredrik B Thorén

HLA-B*44 and the Bw4-80T motif are associated with poor outcome of relapse-preventive immunotherapy in acute myeloid leukemia

HLA-B*44 和 Bw4-80T 基序与急性髓系白血病复发预防性免疫治疗的不良预后相关。

Hana Komic # ,Alexander Hallner # ,Brwa Ali Hussein ,Chiara Badami ,Anne Wöhr ,Kristoffer Hellstrand ,Elin Bernson ,Fredrik B Thorén

Impact of NK Cell Activating Receptor Gene Variants on Receptor Expression and Outcome of Immunotherapy in Acute Myeloid Leukemia

NK 细胞活化受体基因变异对急性髓系白血病受体表达和免疫治疗结果的影响

Brwa Ali Hussein, Alexander Hallner, Lovisa Wennström, Mats Brune, Anna Martner, Kristoffer Hellstrand, Elin Bernson, Fredrik B Thorén

The HLA-B -21 dimorphism impacts on NK cell education and clinical outcome of immunotherapy in acute myeloid leukemia

HLA-B -21 二态性影响 NK 细胞的发育和急性髓系白血病免疫治疗的临床结果

Alexander Hallner ,Elin Bernson ,Brwa Ali Hussein ,Frida Ewald Sander ,Mats Brune ,Johan Aurelius ,Anna Martner ,Kristoffer Hellstrand ,Fredrik B Thorén

Determinants for Effective ALECSAT Immunotherapy Treatment on Autologous Patient-Derived Glioblastoma Stem Cells

对患者自体来源的胶质母细胞瘤干细胞进行有效的 ALECSAT 免疫治疗的决定因素

Anna Wenger, Katja Werlenius, Alexander Hallner, Fredrik Bergh Thorén, Dan Farahmand, Magnus Tisell, Anja Smits, Bertil Rydenhag, Asgeir S Jakola, Helena Carén